ERVEBO is an Ebola Zaire vaccine
Tradename: ERVEBO Proper Name: Ebola Zaire Vaccine, Live Indication: To extend the indication for use to include individuals 12 months of age and older. ERVEBO is a vaccine indicated for…
Xdemvy to treat Demodex blepharitis
Name: Xdemvy Indications: To treat Demodex blepharitis. Active Ingredient: Lotilaner Company: Tarsus Pharmaceuticals, Inc. Approval Date: 7/25/2023 More Details: https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/217603s000lbl.pdf
BALFAXAR for reversal of acquired coagulation factor
Tradename: BALFAXAR Proper Name: prothrombin complex concentrate, human-lans Indication: Indicated for the urgent reversal of acquired coagulation factor deficiency induced by Vitamin K antagonist (VKA, e.g., warfarin) therapy in adult…
Vanflyta to treat myeloid leukemia
Name: Vanflyta Indications: To use as part of a treatment regimen for newly diagnosed acute myeloid leukemia that meets certain criteria. Active Ingredient: Quizartinib Company: Daiichi Sankyo, Inc Approval Date:…
CYFENDUS vaccine for prophylaxis following exposure to Bacillus anthracis
Tradename: CYFENDUS Proper Name: Anthrax Vaccine Adsorbed, Adjuvanted Indication: Indicated for post-exposure prophylaxis of disease following suspected or confirmed exposure to Bacillus anthracis in persons 18 through 65 years of…